Aquestive Therapeutics Inc. (AQST)
Market is closed
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
- 1 - 5
- Next >>
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Balyasny Asset Management Dmitry Balyasny | 2,900,570 | $12,037,366 | +199% | 0.02% |
| 2. | Samsara BioCapital Srini Akkaraju And Michael Dybbs | 2,500,000 | $10,375,000 | 1.01% | |
| 3. | Sio Capital Michael Castor | 1,922,887 | $7,979,981 | +94% | 1.14% |
| 4. | Two Sigma Advisors John Overdeck And David Siegel | 1,139,404 | $4,728,527 | +243% | 0% |
| 5. | Propel Bio Management Leen Kawas And Richard Kayne | 710,988 | $2,950,600 | 1.86% |
Hedge Fund Resource Center